Changes and Clinical Significances of Levels of Serum CysC and β2-MG and Blood Gas Indexes Before and After Treatment of COPD with Type Ⅱ Respiratory Failure

LUO Li, LUO Li

PDF(1240 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1240 KB)
Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (4) : 661-665. DOI: 10.11748/bjmy.issn.1006-1703.2022.04.026
Clinical Investigation

Changes and Clinical Significances of Levels of Serum CysC and β2-MG and Blood Gas Indexes Before and After Treatment of COPD with Type Ⅱ Respiratory Failure

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(4): 661-665 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.04.026

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1240 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-2
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　E-mail: bjmy@circ.com.cn

/

〈 〉